| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 235.0 | 154.2 |
| Gross profit | 204.3 | 126.2 |
| Profit before tax | 53.7 | -1.6 |
| Net income | 57.4 | -1.8 |
| EPS (diluted, $ a share) | $0.66 | $-0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +52.4% |
|---|---|
| Gross margin | 87.0% |
| Operating margin | 21.4% |
10-Q filed with the SEC, NYSE: HNGE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Hinge Health, Inc.: key numbers
- Share price
- $121.29Close, Nov 16
- Sector
- Technology
- Industry
- Services-Computer Processing & Data PreparationSIC 7374
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Hinge Health, Inc.
All →Hinge Health Director Gabriel M.i. Mecklenburg Sells $24.5M of Stock
Gabriel M.i. Mecklenburg, Director, sold 200,000 shares of Hinge Health, Inc. at $121.76 to $125.50 a share (average $122.41) in 5 transactions, worth $24.5M in total on Nov 11, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $24.5M
- Shares
- 200,000
- Average price
- $122.41
- Role
- Director
- Holding change
- -100.0%
- Trade date
- Nov 11, 2026
Hinge Health CFO James Budge Sells $4.37M of Stock
James Budge, CFO, sold 35,907 shares of Hinge Health, Inc. at $119.52 to $123.34 a share (average $121.62) in 5 transactions, worth $4.37M in total on Nov 10, 2026. Shares held after the trade: 256,207 (-2.1%).
- Value
- $4.37M
- Shares
- 35,907
- Average price
- $121.62
- Role
- CFO
- Holding change
- -2.1%
- Trade date
- Nov 10, 2026
Hinge Health Financial Results
Hinge Health reported record Q3 2026 results with revenue growing 52% year-over-year to $235 million and a significant increase in non-GAAP operating margin to 33%. The company raised its full-year 2026 revenue guidance to approximately $880 million and announced that President James Pursley will transition to a role on the Board of Directors in January 2027.
- Term
- Q3 2026
“Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale. This focus on the triple aim, via a technology platform that scales and automates care delivery, is also resulting in a record sales season.”
Daniel Perez, Co-Founder and CEO
“We wouldn't be the company we are today if not for Jim. He's been instrumental in our scaling to over 3,200 clients. I'm grateful for all he's done and that he'll continue contributing to our success as a board member and advisor.”
Daniel Perez, Co-Founder and CEO
Hinge Health CFO James Budge Sells $4.92M of Stock
James Budge, CFO, sold 47,720 shares of Hinge Health, Inc. at $101.53 to $104.33 a share (average $103.13) in 4 transactions, worth $4.92M in total on Oct 12, 2026. Shares held after the trade: 296,728 (-3.1%).
- Value
- $4.92M
- Shares
- 47,720
- Average price
- $103.13
- Role
- CFO
- Holding change
- -3.1%
- Trade date
- Oct 12, 2026
Hinge Health Director Gabriel M.i. Mecklenburg Sells $20.6M of Stock
Gabriel M.i. Mecklenburg, Director, sold 200,000 shares of Hinge Health, Inc. at $101.53 to $104.34 a share (average $103.13) in 4 transactions, worth $20.6M in total on Oct 12, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $20.6M
- Shares
- 200,000
- Average price
- $103.13
- Role
- Director
- Holding change
- -100.0%
- Trade date
- Oct 12, 2026
Hinge Health CEO & Co-Founder Daniel Antonio Perez Sells $411K of Stock
Daniel Antonio Perez, CEO & Co-Founder, sold 4,100 shares of Hinge Health, Inc. at $100.20 a share, worth $411K in total on Oct 6, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $411K
- Shares
- 4,100
- Price
- $100.20
- Role
- CEO & Co-Founder
- Holding change
- -100.0%
- Trade date
- Oct 6, 2026